Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 12/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | RELA | Q04206 | 1/20 | 0.63 |
| ▸ | NQO2 | P16083 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.56 |
| ▸ | GRM5 | P41594 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL700304 | 1.00 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL29446272 | 1.00 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL14401249 | 1.00 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL9849735 | 0.93 | NFE2L2 (0.91) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL700536 | 0.93 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL31317689 | 0.93 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL700537 | 0.93 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL698584 | 0.88 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL698583 | 0.88 | NFE2L2 (1.00) | NFE2L2PTGS1PTGS2RELANQO2 | |
| SCHEMBL9849732 | 0.86 | NFE2L2 (0.78) | NFE2L2PTGS1PTGS2RELANQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021074275-A1 | EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE | UNIVERSITE DE RENNES 1 (FR) | 2021-04-22 | — | — | WO | disclosed |
| CN-108658718-B | Preparation method of trans-stilbene compound | 温州大学 | 2020-12-18 | — | — | CN | disclosed |
| CN-111233610-A | Synthesis method of trans-olefin compound | 五邑大学 | 2020-06-05 | — | — | CN | disclosed |
| CN-108658718-A | A kind of preparation method of trans-stilbene compounds | 温州大学 | 2018-10-16 | — | — | CN | disclosed |
| US-9925153-B2 | Therapeutic agents for skin diseases and conditions | STC.UNM (US) | 2018-03-27 | — | — | US | disclosed |
| US-9868873-B2 | Photochromic security enabled ink for digital offset printing applications | XEROX CORPORATION (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160287531-A1 | THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS | STC.UNM | 2016-10-06 | — | — | US | disclosed |
| US-9101920-B2 | Palladium catalyst, method for its preparation and its use | H4SEP KFT (HU) | 2015-08-11 | — | — | US | disclosed |
| US-9056314-B2 | Palladium catalyst, method for its preparation and its use | H4SEP KFT (HU) | 2015-06-16 | — | — | US | disclosed |
| US-8980954-B2 | Substituted cis- and trans-stilbenes as therapeutic agents | STC.UNM (US) | 2015-03-17 | — | — | US | disclosed |
| US-20050244742-A1 | Reimageable medium with light absorbing material | XEROX CORPORATION | 2005-11-03 | — | — | US | disclosed |
| US-20050244743-A1 | Reimageable medium | XEROX CORPORATION. | 2005-11-03 | — | — | US | disclosed |
| EP-1591830-A2 | Reimageable medium | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1591831-A2 | Reimageable medium with light absorbing material | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1591829-A1 | Method for forming temporary image | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5710420-A | Method for embedding and recovering machine-readable information | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| US-5633109-A | Ink compositions with liposomes containing photochromic compounds | XEROX CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160287531-A1 | THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS | CUTA, TSLP, ELANE | NFE2L2 696/4885PTGS1 1081/4885PTGS2 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.